Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Vir Biotechnology Inc., 3 years.
Vir Biotechnology Inc.
Director
Alnylam Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| May 30, 2025 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 8, 2025 | Alnylam Pharmaceuticals Inc. | Grant or award | +775 | — | — |
| May 30, 2024 | Vir Biotechnology Inc. | Grant or award | +8,000 | — | — |
| May 22, 2023 | Vir Biotechnology Inc. | Grant or award | +6,027 | — | — |
| Mar 1, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $22.73 | $56,825 |
| Jan 5, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $24.96 | $62,400 |
| Jan 4, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $25.25 | $63,125 |
| Jan 3, 2023 | Vir Biotechnology Inc. | Open-market purchase | +2,500 | $25.60 | $64,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.